Article
NeurologyLive Friday 5 — April 3, 2020
Author(s):
Take 5 minutes to catch up on NeurologyLive's highlights from the week ending April 3, 2020.
Welcome to NeurologyLive's Friday 5! Every week, the staff compiles 5 highlights of NeurologyLive's widespread coverage in neurology, ranging from newsworthy study findings and FDA action to expert interviews and peer-to-peer panel discussions.
1: Webinar: Multiple Sclerosis Management During COVID-19
Watch Mitzi J. Williams, MD, lead a discussion of the latest best practice guidance and real-world cases of COVID-19 in patients with multiple sclerosis.
2: Cannabidiol Wins FDA Review for Tuberous Sclerosis Complex
The agency has assigned a PDUFA date of July 31, 2020, for the purified CBD treatment which has been previously approved for Dravet and Lennox-Gastaut syndromes.
3: Patricia K. Coyle, MD: The Me-Too Drugs in the MS Pipeline
The director of the MS Comprehensive Care Center and interim chair of the department of neurology at Stony Brook University discussed the need for more originality in the MS pipeline.
4: Mary Rensel, MD: Transitioning to Shared Medical Appointments
The director of Pediatric MS and Wellness programming at the Mellen Center and assistant professor of neurology at Cleveland Clinic Lerner College of Medicine discussed the harsh realities of patients adopting a new treatment method.
5: Please Donate Blood!
NeurologyLive’s parent company, MJH Life Sciences, will be hosting the virtual MJH Life Sciences Sleeves Up Blood Drive from March 31 through April 30.
